Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-30

Clinical Trial Update: Cognitive Impairment Following Sedation for Colonoscopy With Propofol, Midazolam and Fentanyl Combinations [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluated cognitive impairment after colonoscopy sedation using combinations of propofol, midazolam, and fentanyl.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENTANYL (FENTANYL)
  • Midazolam (Midazolam)
  • PROPOFOL (Propofol)

Snippet

Sponsor: Melbourne Health | Conditions: Cognitive Impairment | Phase 4 | Status: COMPLETED